HeartSciences Inc.
HSCS
$3.75
$0.3710.95%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.44% | -54.29% | -19.13% | -50.10% | -13.10% |
| Total Depreciation and Amortization | 4.33% | 21.85% | 137.24% | 24.25% | -74.00% |
| Total Amortization of Deferred Charges | -- | 431.40% | -20.39% | -- | -- |
| Total Other Non-Cash Items | 43.78% | -72.48% | -81.30% | -71.24% | -28.78% |
| Change in Net Operating Assets | 73.61% | 203.10% | -157.88% | 77.54% | 110.25% |
| Cash from Operations | -0.88% | 22.89% | -120.97% | -43.75% | 15.30% |
| Capital Expenditure | 100.00% | 100.00% | 53.62% | -- | -542.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.76% | 61.14% | -155.10% | 83.67% | -- |
| Cash from Investing | 88.73% | 68.09% | -190.00% | 83.67% | -810.53% |
| Total Debt Issued | -- | -- | 453.65% | -- | -- |
| Total Debt Repaid | 3.78% | -41.27% | 30.02% | 22.93% | 39.09% |
| Issuance of Common Stock | -62.03% | -97.26% | -56.73% | 54.01% | -73.77% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -73.48% | -98.03% | 269.55% | 70.07% | -76.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.10% | -120.86% | 39.50% | -35.32% | -369.06% |